PUBLISHER: Grand View Research | PRODUCT CODE: 1772331
PUBLISHER: Grand View Research | PRODUCT CODE: 1772331
The global steviol glycoside market is anticipated to reach USD 7,150.6 million by 2030 and is anticipated to expand at a CAGR of 5.2% during the forecast period, according to a new report by Grand View Research, Inc. Rising health awareness and the demand for low-calorie, natural alternatives have boosted interest in steviol glycoside, zero-calorie sweeteners derived from the stevia plant. As non-glycemic compounds, they appeal to consumers aiming to manage weight, diabetes, and overall wellness, driving their use in functional foods, beverages, and supplements.
The stevioside segment dominated the market with a revenue share of 41.2% in 2024. Stevioside's cost-effectiveness compared to other high-purity stevia extracts makes it an attractive option for large-scale food and beverage manufacturers. Its strong sweetening power, ease of formulation, and stability under heat and acidic conditions also contribute to its widespread use in processed foods, baked goods, and carbonated drinks.
North America market dominated the global landscape. This growth is attributed to the strong regulatory support and Generally Recognized As Safe(GRAS) status granted by the U.S. Food and Drug Administration (FDA), which has encouraged its widespread adoption across food, beverage, medicine, chemicals, paints & coatings and personal care categories. Additionally, advancements in stevia extraction and formulation technologies by regional manufacturers have improved taste profiles, making steviol glycosides more appealing to both consumers and formulators.